Life Sciences Archive » February, 2007

Life Sciences - February, 2007

112 articles

• IntraLase Drops Appeal, Pays Escalon $9.6M
• C.R. Bard Hit With Antitrust, Product Liability Suits
• Celgene, Novartis File Suit Against Generic Ritalin
• Nellson Trustee Asks Court To Reject Settlement
• Mylan Loses Fight For Generic Hypertension Drug
• Ruling Issued On Eye Surgery Patent
• Jones Day Snags Two IP Partners
• Ex-HomeGold CEO Locked Up
• Bristol-Myers Off The Hook In Plavix Probe
• Pipette Maker Claims Rival Infringed Patents
• Former FDA Head Gets Probation, Fine
• Japan To Probe Purported Tamiflu Child Suicides
• Expert IP Litigator Joins Buchanan Ingersoll
• Suit Challenges FDA's Authority Over Cancer Drugs
• Pfizer Loses Bid To Dismiss Adversary Proceeding
• Shareholders Want "Say On Pay"
• Bayoil Founder Loses Bid To Drop Iraqi Kickback Case
• Looking To Go Bigger, IP Vet Joins Robins Kaplan
• Merck Vaccine Sparks Lawsuit
• Sale Of Generic Lipitor Blocked In Denmark
• Attorneys Spared Costs In Cardizem Case
• Medco Health Unit Settles Overbilling Suit For $5.3M
• New HHS Guidelines Clarify Adverse Event Reporting
• Caraco Seeks Judgment On Lexapro Patent
• SonoSite, Zonare Clash Over Ultrasound Patent
• Merck Donated To Vaccine-Friendly Governor: Report
• ITC Judge To Rehear Smallpox Patent Fight
• USPTO Delivers Setback To Genentech
• Hospital Sued For Washing Scalpels In Elevator Fluid
• Spat Over Cold Medicine Leads To Suits
• Medical Device Co. Receives FDA Warning
• Catheter Maker Seeks To Overturn Jury Verdict
• Merck Backs Away From Gardasil Lobbying
• Using Citizen Petitions To Harm Competition
• ADHD Drug Makers Must Warn Of Side Effects: FDA
• Ex-Biopure CEO Settles Blood Substitute Case
• Suits Pile Up Over Human Tissue
• Preview Of KSR V. Teleflex
• Serono Agrees To $24M Settlement Over AIDS Drug
• Wyeth Loses 2nd Prempro Trial; Jury Awards $3M
• Enzyme Patent Dispute Settled For $8.2M
• Hungarian Drug Maker Triumphs Over Merck
• Restless Leg Drug Triggers Gambling Habit: Suits
• Supreme Court Hearing Set For Microsoft, AT&T Case
• Testimony Wraps Up In Plavix Trial
• AAI Cautions FTC On Carmark-Express Scripts Union
• Pfizer Drug Supply Deal Draws Antitrust Scrutiny
• Government Raids Ranbaxy's Offices
• Judge Approves SeraCare Reorganization Plan
• Solutia Creditors Seek To Force Mediation
• Wyeth Garners Victory In Prempro Trial
• Novartis Tightens Stance Over Gleevec In India
• Generic Biologics Bill Reintroduced
• Injunction Issued Over Zyprexa Leak
• Merck Agrees To $2.3B Settlement With IRS
• Congress, Fed. Circ. To Review Willfulness Doctrine
• Cohen Milstein Tops Antitrust Plaintiffs Ranking
• Williams Bailey Ranked #1 In Product Liability Litigation
• Reed Smith Ranked #1 In Product Liability Defense
• Employment Litigation Trends: Health Care
• America's Most Litigious Health Care Companies
• Mayer Brown Ranked #1 In Antitrust Defense
• Fish & Richardson Ranked #1 In Patent Litigation
• Antitrust Litigation Trends: Health Care
• Product Liability Litigation Trends: Health Care
• IP Litigation Trends: Health Care
• Littler Ranked #1 In Employment Litigation
• J&J Staves Off Generic Topamax
• Court Halts Caremark-CVS Merger Vote
• Number Of Suits Against Medtronic Spikes
• FDA Restricts Use Of Sanofi-Aventis Drug
• Sanofi-Aventis To Appeal Lovenox Verdict
• Abbott Ordered To Pay $6M In Discrimination Suit
• Judge Calls For New Trial In Fresenius Case
• J&J May Have Violated Foreign Corrupt Practices Act
• Sealed Documents Challenged In Zyprexa Case
• Thailand Threatens More Compulsory Licenses
• Glaxo, Watson Strike $35M Deal Over Wellbutrin
• FDA, Cardinal Strike Deal On Defective Drug Pumps
• Patent Attorney, Firm Sued For Malpractice
• Apotex Head Fires Back In Ownership Feud
• Sanofi-Aventis Dealt A Setback
• QLT Unit Pays $112.5M To Resolve Drug Dispute
• Foley Hoag LLP
• Canadian Supreme Court Dismisses Abbott's Appeal
• Court Grants Hemosol Stay
• Amgen Ponders Whether To Seek Injunction
• Family Charged In $3.7M Insider-Trading Scheme
• Medical Device Co. Pulls Endoscopes
• Australia Vows To Shield Blood Plasma Market
• AMS Settles With Celsion Over Prostate Product
• 30 Pharma Cos. Sued In Turkey
• Matrix Latest Target In Teva's Zoloft Battle
• Roche Says It Will Launch Mircera
• Former Exec Sentenced To 20 Years For Fraud
• Sanofi-Aventis Sues Synthon Over Generic Ambien
• King & Spalding Boosts Health Care Group
• Abbott Labs Files Patent Suit Against ImClone
• J&J Closes Acquisition After Injunction Is Denied
• Pfizer Appeals Viagra Ruling In China
• Pfizer's Viagra Case Withers In China
• CVS Warns Rival Bid Riddled With Antitrust Issues
• Court Affirms BrainLAB's Win Against Medtronic
• Wyeth Notches Victory In Texas Prempro Suit
• Senators Propose Host Of Changes For Drug Industry
• Avian Flu Vaccine Makers Exempt From Liability
• Federal Circuit Says U.S. Can't Decide Foreign Patents
• Judge Reverses Return Of Disclosed E-mails
• Glaxo Seeks Ban on Ranbaxy's Herpes Drug
• Pharmacy Board Retreats From Generic Opposition
• PTO Shoots Down Benitec's Patent Claims
• Medtronic Sues Over Alloy Device Patents